Dr Shen on Adjuvant CDK4/6 Inhibitors in HR+/HER2– Breast Cancer
Sherry Shen, MD, assistant attending physician, breast oncologist, Memorial Sloan Kettering Cancer Center, discusses findings from the phase 3 monarchE (NCT03155997) and NATALEE (NCT03701334) trials evaluating adjuvant CDK4/6 inhibitors in patients …